General Dermatology

Catch up on dermatology news, highlights, and insights from the past 24 hours.

This month and all year round, we recognize the strides and contributions of female leaders in dermatology.

Exclusive Q1 Report: A comprehensive look at the latest FDA approvals and pipeline developments in dermatology from the first quarter of 2025.

Explore the top headlines of the week including insights on clinical trials, CBD products, and more.

Test your knowledge of key words and terms associated with dermatology news from the previous week.

In case you missed it, this week we had news about CBD products in dermatology, Journey Medical's launch of Emrosi for rosacea, the psychological impact of melanoma, and more.

This week, we feature top articles from our sister publications on clinical trials, FDA updates, and more.

Catch up on dermatology news, highlights, and insights from the past 24 hours.

Learn more about the in-depth topics covered in the March 2025 print issue of Dermatology Times.

Explore the top headlines of the week including insights on recalls, expert pearls, and more.

Dermatology Times is looking back on the top stories in dermatology from the month of March.

Catch up on dermatology news, highlights, and insights from the past 24 hours.

In a prospective study, patients with scalp seborrheic dermatitis saw positive results in efficacy, safety, and quality of life when using the AgNP product.

Dermatology Times is recapping our exclusive expert interviews from the month of March.

Catch up on dermatology news, highlights, and insights from the past 24 hours.

This review of the latest dermatologic studies includes insights into atopic dermatitis, including results from a novel topical CBD application, skin mycobiome comparison, and more.

Catch up on dermatology news, highlights, and insights from the past 24 hours.

Research suggests that neomycin allergy may be underdiagnosed despite its common use in medical and cosmetic formulations.

Catch up on dermatology news, highlights, and insights from the past 24 hours.

Researchers have identified elevated eosinophil levels as a potential marker for chronic urticaria in pediatric patients.

As a featured clinician in EltaMD’s Derm Day campaign, Mona Gohara, MD, spoke about her connection with the brand and the work being done to unify dermatologists and promote skin health.

Explore the top headlines of the week including insights on voluntary recalls, DIMIDs and pandemic risks, and AAD pearls.

Test your knowledge of key words and terms associated with dermatology news from the previous week.

In case you missed it, this week we had news about positive results from Incyte’s phase 3 STOP-HS trials, multidisciplinary approaches to advanced BCC and CSCC, pediatric ocular adverse effects associated with dupilumab, and more.

This week, we feature top articles from our sister publications on long COVID recovery, integrating AI into pharmacy, and more.